Novel heterozygous variants in the EP300 gene cause Rubinstein–Taybi syndrome 2: Reports from two Chinese children
Molecular Genetics & Genomic Medicine · 2023
DOI: 10.1002/mgg3.2192 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Caiqi Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Rubinstein-Taybi Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Rubinstein–Taybi syndrome (RSTS) is a rare autosomal‐dominant genetic disease caused by variants of CREBBP (RSTS1) or EP300 (RSTS2) gene. RSTS2 is much less common, with less than 200 reported cases worldwide to date. More reports are still needed to increase the understanding of its clinical manifestations and genetic characteristics.
Methods
The clinical data of two children with RSTS2 were analyzed retrospectively, and their clinical manifestations, auxiliary examinations, and mutational spectrum were summarized. Liquid chromatography–tandem mass spectrometer (LC–MS/MS) technology was used to detect the levels of steroid hormones if possible.
Results
After analyzing the clinical and genetic characteristics of two boys with RSTS2 (0.7 and 10.4 years old, respectively) admitted in our hospital, we identified two novel heterozygous variants in the EP300 exon 22 (c.3750C > A, p. Cys1250*, pathogenic; c.1889A > G, p. Tyr630Cys, likely pathogenic), which could account for their phenotype. In addition to common clinical manifestations such as special facial features, microcephaly, growth retardation, intellectual disability, speech delay, congenital heart defect, recurrent respiratory infections, and immunodeficiency, we found one of them had a rare feature of adrenal insufficiency, and LC–MS/MS detection showed an overall decrease in steroid hormones.
Conclusion
In our study, we identified two novel variants in the EP300 exon 22, and for the first time, we reported a case of RSTS2 associated with adrenal insufficiency, which will enrich the clinical and mutational spectrum of this syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Endocrinology, Shenzhen Children's Hospital, Shenzhen, China.
ORCID-Profile: Caiqi Du, Zhuoguang Li, Yan Liang
Zitieren
APA
Du, C., Li, Z., Zou, B., Li, X., Chen, F., Liang, Y., Luo, X., & Shu, S. (2023). Novel heterozygous variants in the EP300 gene cause Rubinstein–Taybi syndrome 2: Reports from two Chinese children. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2192
Vancouver
Du C, Li Z, Zou B, Li X, Chen F, Liang Y, et al. Novel heterozygous variants in the EP300 gene cause Rubinstein–Taybi syndrome 2: Reports from two Chinese children. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2192
BibTeX
@article{Du2023,
author = {Du, Caiqi and Li, Zhuoguang and Zou, Biao and Li, Xuesong and Chen, Fan and Liang, Yan and Luo, Xiaoping and Shu, Sainan},
title = {Novel heterozygous variants in the EP300 gene cause Rubinstein–Taybi syndrome 2: Reports from two Chinese children},
journal = {Molecular Genetics & Genomic Medicine},
year = {2023},
doi = {10.1002/mgg3.2192}
}
EUVIMED